69 related articles for article (PubMed ID: 7694372)
21. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
Petukhov VI; Strozha IL; Bondare DK
Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
[No Abstract] [Full Text] [Related]
22. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
Carreras E
Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
[No Abstract] [Full Text] [Related]
23. [Status of recombinant cytokines in treatment of leukemic diseases].
Geissler K
Wien Med Wochenschr; 1991; 141(9-10):217-20. PubMed ID: 1949848
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte colony-stimulating factor reverses cytopenia and may permit cytogenetic responses in patients with chronic myeloid leukemia treated with imatinib mesylate.
Marin D; Marktel S; Foot N; Bua M; Goldman JM; Apperley JF
Haematologica; 2003 Feb; 88(2):227-9. PubMed ID: 12604417
[No Abstract] [Full Text] [Related]
25. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
26. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
[No Abstract] [Full Text] [Related]
27. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
28. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
29. [Interferon-alpha therapy in chronic myeloid leukemia].
Lutz D
Wien Med Wochenschr; 1993; 143(16-17):416-9. PubMed ID: 8273364
[TBL] [Abstract][Full Text] [Related]
30. Autologous bone marrow transplantation in chronic myeloid leukaemia.
Divya
Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
[No Abstract] [Full Text] [Related]
31. Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: back to the bench.
Hui CH; Hughes TP
Leuk Lymphoma; 2006 Sep; 47(9):1721-3. PubMed ID: 17064975
[No Abstract] [Full Text] [Related]
32. Exciting times for our field and the Journal.
Humphries RK
Exp Hematol; 2011 Mar; 39(3):271. PubMed ID: 21277347
[No Abstract] [Full Text] [Related]
33. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
34. [Contribution of cytokines in the treatment of human cancers].
Marty M; Extra JM; Dieras V
Pathol Biol (Paris); 1990 Oct; 38(8):783-5. PubMed ID: 1703291
[No Abstract] [Full Text] [Related]
35. [Properties of leukemic stem cells and treatment strategy for the cure of chronic myelogenous leukemia].
Minami Y
Rinsho Ketsueki; 2013 Jun; 54(6):552-8. PubMed ID: 23823094
[No Abstract] [Full Text] [Related]
36. Chromosomal aberrations during interferon therapy for chronic myelogenous leukemia.
Hild F; Freund M; Fonatsch C
N Engl J Med; 1991 Jul; 325(2):132. PubMed ID: 2052050
[No Abstract] [Full Text] [Related]
37. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.
Mahon FX; Montastruc M; Faberes C; Reiffers J
Blood; 1994 Nov; 84(10):3592-4. PubMed ID: 7832859
[No Abstract] [Full Text] [Related]
38. [Cytokine therapy for hematological malignancies].
Tojo A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():279-84. PubMed ID: 23133968
[No Abstract] [Full Text] [Related]
39. Angiogenesis in chronic myelogenous leukaemia.
Garland JM; Kumar S; Heagerty A
Lancet; 2000 Sep; 356(9234):1026-7. PubMed ID: 11041417
[No Abstract] [Full Text] [Related]
40. Adhesive defects in chronic myeloid leukemia.
Gordon MY; Dowding CR; Riley GP; Goldman JM; Greaves MF
Curr Top Microbiol Immunol; 1989; 149():151-5. PubMed ID: 2659279
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
